https://www.selleckchem.com/pr....oducts/tradipitant.h
8 ± 1.1 and 6.1 ± 1.0, respectively. Six months after treatment, the VAS score was reduced to 1.9 ± 0.9 and 5.1 ± 1.0, respectively. The ESWT group had a MHQ score of 54.4 ± 7.7 before treatment and 73.3 ± 6.8 six months after. The control group had a MHQ score of 54.2 ± 7.1 before treatment and 57.8 ± 4.4 six months after. ESWT is an effective and a safe non-invasive treatment option for pain management and hand functionality in pillar pain. ESWT is an effective and a safe non-invasive treatment option for pain management and hand
Like
Comment
Share
